Home > D. General pathology > Genetic and developmental anomalies > Frasier syndrome
Frasier syndrome
Thursday 8 April 2004
Definition: Frasier syndrome is a rare disorder defined by gonadal dysgenesis, male pseudohermaphroditism and progressive glomerulopathy. It is caused by mutations in the donor splice site in intron 9 of the WT1 gene.
The occurrence of symptoms is associated with a decrease in the ratio of the lysine-threonine-serine (+/- KTS) isoform of the WT1 protein.
Mutations in the WT1 gene are present in children with Frasier syndrome, Denys-Drash syndrome, WAGR syndrome, and some cases of Wilms tumor.
WT1 is necessary for normal urogenital development.
Frasier syndrome is an association between focal segmental glomerulosclerosis, beginning in the second and third decade, male to female sex reversal, and dysgenetic gonads.
Early prophylactic resection of dysgenetic gonads is indicated in children with Frasier syndrome to prevent the development of germ cell malignancy.
Synopsis
46,XY male to female sex reversal (46,XY phenotypic female)
- male pseudohermaphroditism with retentio testis
- hypoplastic uterus
- cord-like gonadal structures
- gonadal dysgenesis (dysgenetic gonads)
- foci of gonadoblastoma in dysgenetic gonads
- hypospadias
- cryptorchidism
in females
- atrophic ovaries
nephrotic syndrome
- diffuse mesangial sclerosis
- nonspecific focal and segmental glomerulosclerosis (FSGS)
tumoral predisposition
- gonadoblastoma in situ
- early gonadoblastoma (17101338, 20419325, 19653292)
- bilateraal gonadoblastoma (19653292)
- seminoma/dysgerminoma (17101338, 20408995, 19653292)
Etiology
constitutional mutations in the WT1 gene
- donor splice site heterozygous mutations in intron 9
- donor site mutation IVS9+5G>A of the splice site in the intron 9
- The ratio of +/-KTS splice variants of the Wilms’ tumour suppressor protein WT1 mRNA is determined by an intronic enhancer. (18756326)
See also
Denys-Drash syndrome
References
A female infant with Frasier syndrome showing splice site mutation in Wilms’ tumor gene (WT1) intron 9. Fujita S, Sugimoto K, Miyazawa T, Yanagida H, Tabata N, Okada M, Takemura T. Clin Nephrol. 2010 Jun;73(6):487-91.PMID: 20497763
Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness. Sinha A, Sharma S, Gulati A, Sharma A, Agarwala S, Hari P, Bagga A. Pediatr Nephrol. 2010 Oct;25(10):2171-4. PMID: 20419325
Recurrence of a dysgerminoma in Frasier syndrome. Mestrallet G, Bertholet-Thomas A, Ranchin B, Bouvier R, Frappaz D, Cochat P. Pediatr Transplant. 2010 Apr 8. PMID: 20408995
Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome. Subbiah V, Huff V, Wolff JE, Ketonen L, Lang FF Jr, Stewart J, Langford L, Herzog CE. Pediatr Blood Cancer. 2009 Dec 15;53(7):1349-51. PMID: 19653292
Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Schumacher V, Gueler B, Looijenga LH, Becker JU, Amann K, Engers R, Dotsch J, Stoop H, Schulz W, Royer-Pokora B. Mol Reprod Dev. 2008 Sep;75(9):1484-94.PMID: 18271004
Management of Wilms tumors in Drash and Frasier syndromes. Auber F, Jeanpierre C, Denamur E, Jaubert F, Schleiermacher G, Patte C, Cabrol S, Leverger G, Nihoul-Fékété C, Sarnacki S. Pediatr Blood Cancer. 2009 Jan;52(1):55-9. PMID: 18816692
The ratio of +/-KTS splice variants of the Wilms’ tumour suppressor protein WT1 mRNA is determined by an intronic enhancer. Yang C, Romaniuk PJ. Biochem Cell Biol. 2008 Aug;86(4):312-21. PMID: 18756326
Expanding the clinical spectrum of Frasier syndrome. Gwin K, Cajaiba M, Caminoa-Lizarralde A, Picazo M, Nistal M, Reyes-Mugica M. Pediatr Dev Pathol. 2007 Mar 22:1 PMID: 17378674
Prophylactic bilateral salpingo-oopherectomy in a 17-year-old with Frasier syndrome reveals gonadoblastoma and seminoma: a case report. Love JD, DeMartini SD, Coppola CP. J Pediatr Surg. 2006 Nov;41(11):e1-4. PMID: 17101338
The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms’ tumor. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, Papathanasiou A, Tar A, Merksz M, Gyorvari B, Sultan C, Dumas R, Jaubert F, Niaudet P, Moreira-Filho CA, Cotinot C, Fellous M. Hum Mutat. 1999;13(2):146-53. PMID: #10094551
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K. Nat Genet. 1997 Dec;17(4):467-70. PMID: 9398852